Clinical studies with non-iressa EGFR tyrosine kinase inhibitors-Reference-Cited by-同舟云学术

Clinical studies with non-iressa EGFR tyrosine kinase inhibitors

Published:2003-08 Issue: Volume:41 Page:43-48
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Bonomi Philip

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference24 articles.

1. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials;Br. Med. J.,1995

2. Third generation chemotherapy regimens (3GR) improve survival over second generation regimens (2GR) in stage IIIB.IV non-small cell lung cancer (NSCLC): a meta-analysis of the published literature;Baggstram;Proc. Am. Soc. Clin. Oncol.,2002

3. Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small cell lung cancer: a Southwest oncology group trial;Kelly;J. Clin. Oncol.,2001

4. Comparison of four chemotherapy regimens for advanced non-small cell lung cancer;Schiller;New Engl. J. Med.,2002

5. The hallmarks of cancer;Hanahan;Cell,2000

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Irreversible Enzyme Inactivators;Evaluation of Enzyme Inhibitors in Drug Discovery;2013-05-06

2. Monitoring Predominantly Cytostatic Treatment Response with 18F-FDG PET;Journal of Nuclear Medicine;2009-04-29

3. Induction of Na+/K+/2Cl− cotransporter expression mediates chronic potentiation of intestinal epithelial Cl− secretion by EGF;American Journal of Physiology-Cell Physiology;2008-06

4. EGFR-Targeted Therapeutics: Focus on SCCHN and NSCLC;The Scientific World JOURNAL;2008

5. The emerging role of epidermal growth factor receptor inhibitors in ovarian cancer;International Journal of Gynecologic Cancer;2008